In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 3 selected

Type

Guidance programme 10 selected

Guidance programme

Showing 1 to 10 of 10

TitleConsultationTypeConsultation end date
Fosdenopterin for treating molybdenum cofactor deficiency type A [ID6264]Evaluation consultationHighly specialised technology
Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary interventionInterventional procedure consultationInterventional procedures guidance
Rozanolixizumab for treating antibody-positive generalised myasthenia gravis [ID5092]Draft guidanceTechnology appraisal guidance
Pegzilarginase for treating arginase-1 deficiency [ID4029]Evaluation consultationHighly specialised technology
Zolbetuximab with chemotherapy for untreated claudin 18.2-positive HER2 negative unresectable advanced gastric or gastro-oesophageal junction adenocarcinoma [ID5123]Draft guidanceTechnology appraisal guidance
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertensionInterventional procedure consultationInterventional procedures guidance
Electrically stimulated intravesical therapy for interstitial cystitis or overactive bladderInterventional procedure consultationInterventional procedures guidance
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitisInterventional procedure consultationInterventional procedures guidance
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis (Review of TA756) [ID5115]Draft guidanceTechnology appraisal guidance
Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All